advertisement
11.14 Investigational drugs; pharmacological experiments (7)
Showing records 1 to 7
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments11965 Fadolmidine-induced ocular hypotension in normotensive rabbits
Savolainen J; Niemi R; Mantyla A; Huuskonen J; Jarvinen T
Journal of Pharmacy and Pharmacology 2005; 57: 191-195
12105 The anandamide membrane transporter and the therapeutic implications of its inhibition
Battista N; Gasperi V; Fezza F; Maccarrone M
Therapy 2005; 2: 141-150
11770 β-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane
Glennon RA; Bondarev ML; Khorana N; Young R; May JA; Hellberg MR; McLaughlin MA; Sharif NA
Journal of Medicinal Chemistry 2004; 47: 6034-6041
11917 The rabbit's IOP after instillation of antiglaucomatic COSOPT and aminoacid L-argininin. HCL mixture in the conjunctival sac
Olah Z; Veselovsky J; Gressnerova S; Vesela A
Česka a Slovenska Oftalmologie 2005; 61: 3-12
11934 Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma
Pintor J
Current Opinion in Investigational Drugs 2005; 6: 76-80
11976 Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes
Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 489-508
12005 Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys
Tian B; Kaufman PL
Experimental Eye Research 2005; 80: 215-225
